SANA
SANA clinical trials: Sana Biotechnology, Inc.
Every trial on ClinicalTrials.gov where Sana Biotechnology, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 4
- Trials linked
- 3
- As lead sponsor
- 1
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
SANA on the catalyst calendar · SANA registry changes
- Primary completion Dec 2027Sponsor estimatePhase 1NCT06294236Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)Sana Biotechnology · Lupus ErythematosusActive, not recruitingSANALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2025Sponsor estimatePhase 1NCT06285422Study Evaluating SC262 in Subjects With r/r Non-Hodgkin's Lymphoma (VIVID)Sana Biotechnology · Non Hodgkin's LymphomaActive, not recruitingSANALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 4, 2025Sponsor estimatePhase 1NCT05878184Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT)Sana Biotechnology · Non Hodgkin LymphomaActive, not recruitingSANALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2025Sponsor estimateEarly Phase 1NCT06239636First-in-human Safety Study of Hypoimmune Pancreatic Islet Transplantation in Adult Subjects With Type 1 DiabetesPer-Ola Carlsson · Type1diabetesRecruitingSANACollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 4 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner